Criteria for the choice and definition of healthy volunteers and or patients for phase I and phase II studies in drug development. Commentary on an action for cooperative research.
Service de Pharmacologie Clinique-CHU Jean Minjoz, Besançon, France.
P R
PR
Bechtel
G
G
Alvan
D004341:Drug Evaluation; D005060:Europe; D006801:Humans; D007391:International Cooperation; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic